Galectin Therapeutics
GALT
#8751
Rank
C$0.31 B
Marketcap
C$4.78
Share price
0.30%
Change (1 day)
13.41%
Change (1 year)

Earnings for Galectin Therapeutics (GALT)

Earnings in 2026 (TTM): -C$36.18 Million

According to Galectin Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -C$43.49 Million, an increase over its 2024 earnings that were of -C$66.34 Million. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Galectin Therapeutics from 2002 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$36.18 Million-16.8%
2025 -C$43.49 Million-34.46%
2024 -C$66.34 Million14.56%
2023 -C$57.91 Million5.91%
2022 -C$54.68 Million27.02%
2021 -C$43.05 Million30.1%
2020 -C$33.09 Million76.51%
2019 -C$18.75 Million-4.36%
2018 -C$19.6 Million-14.38%
2017 -C$22.9 Million-24.26%
2016 -C$30.23 Million7.04%
2015 -C$28.24 Million26.85%
2014 -C$22.27 Million30.61%
2013 -C$17.05 Million27.82%
2012 -C$13.34 Million-9.15%
2011 -C$14.68 Million113.17%
2010 -C$6.89 Million-19.86%
2009 -C$8.6 Million14.4%
2008 -C$7.51 Million-17.49%
2007 -C$9.11 Million-8.41%
2006 -C$9.94 Million5.91%
2005 -C$9.39 Million-8.89%
2004 -C$10.3 Million47.92%
2003 -C$6.97 Million50.22%
2002 -C$4.64 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Mirati Therapeutics
MRTX
-C$1.08 Billion 2,813.68%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
-C$40.3 Million 8.86%๐Ÿ‡บ๐Ÿ‡ธ USA